Achieve Life Sciences (NASDAQ:ACHV – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They presently have a $12.00 price objective on the biopharmaceutical company’s stock. HC Wainwright’s price target would indicate a potential upside of 125.14% from the […]